| Serial Number | 90750624 |
| Word Mark | ZENBEXUS |
| Filing Date | Wednesday, June 2, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Tuesday, October 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, September 6, 2022 |
| Description of Mark | The mark consists of the word ZENBEXUS in blue stylized font except for a red and yellow stylized "x". |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical and biological preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders, and monoclonal antibodies for medical use |
| Indication of Colors claimed | The color(s) blue, red and yellow is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 29, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Celgene Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Party Name | Celgene Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Event Date | Event Description |
| Saturday, June 5, 2021 | NEW APPLICATION ENTERED |
| Wednesday, August 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 20, 2022 | ASSIGNED TO EXAMINER |
| Thursday, January 27, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, January 27, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, January 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 29, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 29, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, July 29, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, July 29, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, July 30, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 17, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 6, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 6, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 1, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, April 24, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 24, 2023 | SOU EXTENSION 1 FILED |
| Monday, April 24, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, October 12, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 12, 2023 | SOU EXTENSION 2 FILED |
| Thursday, October 12, 2023 | SOU EXTENSION 2 GRANTED |
| Saturday, October 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 26, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, April 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 29, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 29, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 29, 2024 | SOU EXTENSION 4 GRANTED |
| Tuesday, October 29, 2024 | SOU EXTENSION 4 FILED |
| Friday, April 5, 2024 | SOU EXTENSION 3 FILED |
| Friday, April 5, 2024 | SOU EXTENSION 3 GRANTED |